Adjunct cyclosporine therapy for refractory Kawasaki disease in a very young infant

Seigo Okada, Yoshihiro Azuma, Yasuo Suzuki, Hiroko Yamada, Midori Wakabayashi-Takahara, Yuno Korenaga, Hideaki Akase, Shunji Hasegawa, Shouichi Ohga

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Herein we describe the case of a 6-week-old boy who developed complete Kawasaki disease (KD). The cytokine profile and activation of monocytes and subsequent T cells matched the typical feature of refractory KD. The patient received a total of three courses of i.v. immunoglobulin (IVIG), but did not achieve clinical relief. Adjunctive therapy with oral cyclosporine A (CsA) led to prompt defervescence. This was continued for 7 days without serious adverse events. Coronary artery dilatations regressed within 3 months of follow up. KD infants <3 months of age are at higher risk of coronary artery aneurysm than the older ones. To our knowledge, oral CsA treatment has not been reported in such young infants with KD. The diagnosis and treatment of very young infants with KD are challenging. Adjunctive use of CsA in IVIG treatment could be effective for refractory KD in infants <3 months of age.

Original languageEnglish
Pages (from-to)295-298
Number of pages4
JournalPediatrics International
Issue number4
Publication statusPublished - Apr 1 2016
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Adjunct cyclosporine therapy for refractory Kawasaki disease in a very young infant'. Together they form a unique fingerprint.

Cite this